Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.1530
-0.0040 (-2.55%)
At close: Sep 17, 2026, 4:00 PM EDT
0.1525
-0.0005 (-0.33%)
Pre-market: Sep 18, 2026, 8:31 AM EDT
Catheter Precision Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.92 | 0.82 | 0.42 | 0.44 | 0.01 | 0.02 | |
Revenue Growth | 219.17% | 95.00% | -4.98% | 3057.14% | -36.36% | -91.51% |
Cost of Revenue | 1 | 0.06 | 0.04 | 0.03 | 0.16 | 1.56 |
Gross Profit | 0.91 | 0.76 | 0.38 | 0.41 | -0.15 | -1.54 |
Selling, General & Admin | 12.08 | 12.08 | 11.35 | 17.12 | 16.25 | 15.48 |
Research & Development | 0.9 | 0.86 | 0.27 | 0.48 | 6.39 | 12.25 |
Operating Expenses | 12.97 | 12.94 | 11.62 | 17.6 | 22.64 | 27.73 |
Operating Income | -12.06 | -12.18 | -11.24 | -17.19 | -22.79 | -29.27 |
Interest Expense | -0.49 | -0.28 | -0.09 | - | - | - |
Interest & Investment Income | 0.02 | 0.03 | 0.08 | 0.35 | - | - |
Other Non Operating Income (Expenses) | 11.11 | 5.15 | -2.25 | 7.2 | 0.1 | -0.01 |
EBT Excluding Unusual Items | -1.42 | -7.28 | -13.5 | -9.64 | -22.69 | -29.28 |
Merger & Restructuring Charges | -0.1 | - | - | - | -4.17 | - |
Impairment of Goodwill | - | - | - | -60.93 | - | - |
Asset Writedown | -7 | -7 | - | - | - | - |
Other Unusual Items | -3.37 | -3.26 | - | - | - | 2.02 |
Pretax Income | -13.81 | -19.51 | -13.5 | -70.57 | -26.86 | -27.26 |
Income Tax Expense | -0.62 | -1.81 | 3.14 | - | 0 | 0 |
Earnings From Continuing Operations | -13.19 | -17.7 | -16.64 | -70.57 | -26.87 | -27.26 |
Earnings From Discontinued Operations | - | - | - | - | - | 2.19 |
Net Income to Company | -13.19 | -17.7 | -16.64 | -70.57 | -26.87 | -25.07 |
Minority Interest in Earnings | 0.18 | 0.51 | - | - | - | - |
Net Income | -13.01 | -17.18 | -16.64 | -70.57 | -26.87 | -25.07 |
Preferred Dividends & Other Adjustments | 0.62 | - | 5.16 | 0.8 | - | - |
Net Income to Common | -13.63 | -17.18 | -21.8 | -71.37 | -26.87 | -25.07 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | - | - |
Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | - | - |
Shares Change | 318.71% | 529.09% | 493.94% | - | - | - |
EPS (Basic) | -6.82 | -15.90 | -126.92 | -2467.83 | - | - |
EPS (Diluted) | -6.82 | -15.90 | -126.92 | -2467.83 | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.37 | -8.31 | -9.34 | -20.7 | -22.59 | -27.89 |
Free Cash Flow Per Share | -4.70 | -7.69 | -54.36 | -715.57 | - | - |
Gross Margin | 47.73% | 92.31% | 90.00% | 93.21% | - | - |
Operating Margin | -629.76% | -1487.30% | -2676.91% | -3888.01% | -162778.57% | -133027.27% |
Profit Margin | -711.49% | -2098.05% | -5190.71% | -16147.51% | -191892.86% | -113954.55% |
Free Cash Flow Margin | -489.45% | -1015.02% | -2223.33% | -4682.13% | -161321.43% | -126772.73% |
EBITDA | -10.17 | -10.07 | -9.13 | -15.11 | -22.37 | -28.1 |
D&A For EBITDA | 1.89 | 2.12 | 2.11 | 2.08 | 0.42 | 1.17 |
EBIT | -12.06 | -12.18 | -11.24 | -17.19 | -22.79 | -29.27 |
Revenue as Reported | 1.1 | - | - | - | - | - |
Advertising Expenses | - | 0.17 | 0.17 | 0.1 | - | - |